Enhancing Patient Care in Advanced NSCLC Through Clinician-Patient Partnership.

Slides:



Advertisements
Similar presentations
MEDICAL HOME 1/2009 Mary Goldman, D.O., President of MAOFP.
Advertisements

Cancer Clinical Trials A treatment option for cancer patients.
Connecting South Carolina: The Gibbs/Hollings Cancer Center An NCCCP/NCI Designated Center Connection Anita L. Harrison, MPH Associate Director, Administration.
End of Life Decisions by Adults with Cancer : Role of Religious Practices and Spiritual Beliefs Rudolph M. Navari, M.D., Ph.D. Assistant Dean and Director.
LEARN : Communication to Promote Cultural Sensitivity Listen with sympathy/understanding to the patient's perception of the problem. Explain your perceptions.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.9: Unit 9: The evolution and reform of healthcare in the US 1.9d: The Patient.
HOUSTON METHODIST POPULATION HEALTH MANAGEMENT
The Patient’s Role in the Interprofessional Care Team Orientation The Patient’s Role in the Interprofessional Care Team From the Patient’s Perspective:
Psycho-oncology A physician’s guide.
Su K. Metcalfe, MD, MPH, Michael T
NAVIGATING THE ONCOLOGY PATIENT
The Nurse View: Management of Pancreatic Cancer
Prognosis of younger patients in non-small cell lung cancer
Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer  Timothy R. Wassenaar, MD, Jens C.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Intervista a Angelo Delmonte
Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.
New Patient Journeys in Non-small cell lung cancer
The Nurse View.
T2T Guidelines Promote Shared Decision-Making
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Learning Objectives. A Multidisciplinary Approach in Advanced NSCLC in the Era of Immuno-Oncology.
Organizational Culture in the Oncology Medical Home
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Survivorship Pathway Template
Volume 13, Issue 12, Pages (December 2012)
An Interprofessional Approach to the Patient With Chronic Airway Disease.
Introduction. For Pulmonologists by Pulmonologists: Diagnosis of NSCLC in an Age of Biomarkers.
Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.
Best Practices in Chronic Myeloid Leukemia by Multidisciplinary Teams
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
Talking to Patients About Diabetes Management
SC17.02 Lung Cancer in China: Challenges and Perspectives
Team-Based Perspectives on Successful Approaches in Treating Obesity
From Symptom Management to Communication in Advanced GI Cancers
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Program Goals. Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer.
Engaging Patients and Families as Partners
ADVANCED PARKINSON'S DISEASE:
Male patients with non-small cell lung cancer (NSCLC) have a 24% reduction in the risk of disease progression (A). Male patients with non-small cell lung.
Moving Care Forward in Advanced NSCLC
Nurse View: Practice Pearls in Advanced Pancreatic Adenocarcinoma
Treatment of Stage IV Non-small Cell Lung Cancer
Sandra Winterburn, Senior Lecturer & Consultation Skills Lead
Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.
Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer  Timothy R. Wassenaar, MD, Jens C.
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Overall survival in the IFCT trial comparing a single agent therapy arm (vinorelbine or gemcitabine) and the doublet carboplatin plus weekly paclitaxel.
Management of Advanced Pancreatic Adenocarcinoma
Meta-analysis of randomised phase III clinical trials with ALK inhibitors in non-small cell lung cancer (NSCLC) showing similar benefit in male patients.
Volume 13, Issue 12, Pages (December 2012)
Patient-Centered Management in Advanced Non-Small Cell Lung Cancer
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.
All for One: Multidisciplinary Management in EGFR-Mutated NSCLC
Advanced Parkinson Disease: Are We Breaking New Ground?
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Quality Improvement and Molecular Profiling in Advanced Non-Small Cell Lung Cancer.
P3.02b-062 Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)  Benjamin Besse, Johan.
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy  Naomi E. Verstegen,
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey  Daniel Morgensztern, MD, Shean Huey Ng,
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer  Helen Chow, MD, Martin J.
Journal of Thoracic Oncology
Module 2: What is the Role of the Nurse Navigator?
Towards COP6: Possible elements of a Framework
Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD 
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Presentation transcript:

Enhancing Patient Care in Advanced NSCLC Through Clinician-Patient Partnership

Program Goals

The All-Knowing Physician: Paternalistic Model

The Information Age

Patient Barriers

Physician Attitudes Toward "Participatory" Patients

Clinician-Patient Partnership

Guiding Patients to Credible Information

Online Communities as a Model: Sharing Information

The Role of the Oncology Nurse

Oncology Nurses: Fundamental Elements of Shared Decision Making

Information Retention by Patients

Decision Aids and Other Tools

“Information Prescription”

Advanced Non-Small Cell Lung Cancer

Patient Understanding of Goals of Therapy in Stage IV Disease

Dealing With the “Numbers” Question

Patient Participation in Treatment Decision Making

The Evolution of the Cancer Care Team

Patient Engagement Can Be Time-saving

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)